Medindia

X

Tamiflu substrate produced from Bioengineered Bacteria

by Medindia Content Team on  January 9, 2006 at 8:13 PM Drug News   - G J E 4
Tamiflu substrate produced from Bioengineered Bacteria
The worldwide scare of bird flu pandemic as increased which has lead to stockpiling of large quantities of Tamiflu, antiviral bird flu drug by many countries. U.S. has stocked more than 4 million Tamiflu drugs and many countries have started producing the generic version of the drug Tamiflu manufactured by the Swiss pharmaceuticals Roche.

Advertisement
Due to the gold rush for shikimic acid which is used for production of Tamiflu antiviral drugs, there has been a great shortage of Chinese star anise, which contains high quality pure Shikimic acid. Shikimic acid is obtained from the seeds of Star anise which is grown in the high altitudes in the mountains of Guanxi, Sichuan, Yunnan and Guizhou in Southwestern Chinese province. Due to shortage of Shikimic acid, Roche the manufacturer of Tamiflu is planning to use genetically bioengineered E.coli bacterium to produce shikimic acid by fermentation method. Fermentation procedures uses cheap carbohydrate source which will be used by the bioengineered E.coli as a substrate for production of high quality Shikimic acid.
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: